Researchers at the Instituto de Medicina Molecular in Lisbon, Portugal and the Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil, are making major strides toward understanding the life cycle of flaviviruses, which include some of the most virulent human pathogens: yellow fever virus, Dengue virus and the West Nile Virus, among others.
Today, at the 55th annual meeting of the Biophysical Society in Baltimore, members of the team will report on studies using dengue virus as a model to elucidate the molecular details of the flavivirus life cycle -- work that may lead to new ways to fight Dengue virus infections, for which there are still no treatments and no effective preventative vaccines.
Dengue virus is one of the major causes of viral hemorrhagic fever worldwide, says Ivo Martins, a postdoctoral researcher in the group. About 40 percent of the world's population live in areas where this virus is transmitted. The World Health Organization estimates that 50 million to 100 million people worldwide are infected with Dengue each year, and some 22,000 people die from the virus -- mostly children.
Dengue virus is transmitted by the Aedes aegypti and Aedes albopictus mosquitoes, which are now found throughout the world, including in temperate regions such as the United States and France, where, in 2010, there were several cases of locally transmitted Dengue -- a disease that has been virtually unknown in these countries before.
"The burden that dengue infection (and other flaviviruses) poses on the economy and health systems of affected countries is considerable," says Martins. "Finding a dengue treatment, besides the obvious human health benefits, would thus benefit the economy in those countries immensely."
In Baltimore, Martins will discuss the group's use of biophysical techniques (nuclear magnetic resonance) combined with bioinformatics tools (genome sequence analysis) to elucidate the molecular details of interactions the Dengue virus capsid protein must make in order for it to replicate. In particular, the virus capsid protein must interact with intracellular lipid droplets in order for viral replication to be successful.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.